Press Releases

April 29 2015

Washington, D.C. (April 29, 2015) – The Biotechnology Industry Organization (BIO) today...

February 6 2015

Bill would encourage vaccine research and benefit public health

Washington,...

December 9 2014

Washington, D.C. (December 9, 2014) – The Biotechnology Industry Organization (BIO)...

December 4 2014

Washington, D.C. (December 4, 2014) – Today marks the inaugural meeting of the Blue...

June 20 2013

BIO applauds Sens. Max Baucus (D-MT) and Orrin Hatch (R-UT) and Reps. Jim Gerlach (R-PA) and...

May 24 2013

Rx Response elevates to Alert status to address potential impact from Moore tornado on supply...

April 22 2013

Peer-reviewed article in Vaccine offers actions for bringing vaccines to 90% of the world.

March 5 2013

On March 4, 2013, the U.S. House of Representatives passed PAHPRA by a vote of 370-28.

January 25 2013

Bill will accelerate R&D to help support nation’s preparedness against chemical,...

March 8 2012

The reauthorization of the Pandemic All-Hazards Preparedness Act and the Special Reserve...

November 15 2011

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following...

June 15 2011

High-level members of the Obama Administration will gather with leaders from the...

May 4 2011

The Biotechnology Industry Organization (BIO) announced today its selection of Representative...

April 19 2011

BIO announces that Dr. Jörg Reinhardt, CEO of Bayer HealthCare, will provide the keynote...

February 22 2011

BIO issues statement commending today’s ruling by the U.S. Supreme Court in ...

May 4 2010

A new report issued by the Biotechnology Industry Organization underscores how biotechnology...

May 22 2002

The House of Representatives today voted 425-1 to approve “The Public Health Security...

Letters, Testimony & Comments

July 1 2015
On June 15, 2015, the Department of Defense's (DoD's) Joint Project Manager-Medical Countermeasure Systems (JPM-MCS) held a co-located Industry Day in conjunction with the BIO Convention in Philadelphia, Pennsylvania. The MCS Industry Day focused on industry feedback related to the DoD's proposed use of an Other Transaction Authority (OTA) contracting mechanism. 
March 7 2014
On March 7, 2014, BIO submitted comments to the U.S. Office of Personnel Management (OPM) regarding OPM’s February 4, 2014 Multi-State Plan (MSP) Program Call Letter. BIO’s comments address the critical nature of the Affordable Care Act’s immunization coverage standard.
February 25 2014
BIO joined with the American Pharmacists Association (APhA), Association of State and Territorial Health Officials (ASTHO), Immunization Action Coalition (IAC), Merck, and the National Association of County and City Health Officials (NACCHO) to submit comments to the Centers for Medicare and Medicaid Services (CMS) regarding the February 4, 2014 Draft Letter to Issuers in the Federally-facilitated Marketplaces. 
December 19 2013
BIO submitted comments on the Centers for Medicare and Medicaid Services' (CMS’s) Federally Qualified Health Center (FQHC) Prospective Payment System (PPS) proposed rule, specifically as it relates to vaccine coverage for Medicare beneficiaries and reimbursement for vaccines under Medicare Part B.
July 10 2013
Therapeutic biologics are an opportunity to address unmet patient needs, drive innovation, and assist China's transformation into a knowledge-intensive economy.

Press Releases

January 21 2016
Washington, D.C. (January 21, 2016) – The Biotechnology Innovation Organization (BIO) applauds the Industry Declaration on Combating Antimicrobial Resistance, signed by 85 biopharmaceutical and diagnostic companies and released today at the World Economic Forum in Davos, Switzerland.
April 29 2015
Washington, D.C. (April 29, 2015) – The Biotechnology Industry Organization (BIO) today releases the following statement on the 21st Century Cures Initiative discussion draft shared by Chairman Fred Upton (R-MI), Rep. Diana DeGette (D-CO), Rep. Frank Pallone, Jr. (D-NJ), Rep. Joe Pitts (R-PA), and Rep. Gene Green (D-TX). 
February 6 2015
Bill would encourage vaccine research and benefit public health Washington, D.C. (February 6, 2015) – The Biotechnology Industry Organization (BIO) applauds the introduction of the Vaccine Access, Certainty, and Innovation Act of 2015. Sponsored by Representatives Renee Ellmers (R-NC) and G.K. Butterfield (D-NC), the Act is expected to be an important part of the Energy & Commerce Committee’s 21st Century Cures Initiative and would modernize the discovery, development, and delivery of vaccines. 
December 9 2014
Washington, D.C. (December 9, 2014) – The Biotechnology Industry Organization (BIO) applauds today’s declaration by Health and Human Services Secretary Sylvia M. Burwell under the Public Readiness and Emergency Preparedness (PREP) Act which will help advance the development and availability of experimental Ebola vaccines. The declaration provides immunity under U.S. law against legal claims related to the manufacturing, testing, development, distribution and administration of three experimental Ebola vaccines.
December 4 2014
Washington, D.C. (December 4, 2014) – Today marks the inaugural meeting of the Blue Ribbon Study Panel on Biodefense, a bipartisan panel co-chaired by former Senator Joe Lieberman and former Governor and Homeland Security Secretary Tom Ridge. Panelists former Senator Tom Daschle, former Secretary of Health and Human Services Donna Shalala, former US Homeland Security Advisor Kenneth Wainstein, and Biotechnology Industry Organization (BIO) President and CEO and former Representative Jim Greenwood. The study will be directed by Dr. Robert Kadlec, former special assistant to the President for homeland security and senior director for biological defense policy in the White House Homeland Security Council.